Literature DB >> 15963429

Development of activity standard for 90 Y microspheres.

L Mo1, B Avci, D James, B Simpson, W M Van Wyngaardt, J T Cessna, C Baldock.   

Abstract

(90)Y microspheres are important therapeutic radiopharmaceuticals used in the treatment of liver cancer through a process known as selective internal radiation therapy. SIR-spheres is a radiopharmaceutical product that is comprised of (90)Y microspheres suspended in sterile, pyrogen-free water for injection into patients. It is necessary to establish for the SIR-spheres production the capability of accurately measuring the activity of this product to a traceable national measurement standard. An activity standard for SIR-spheres was developed from a standard for (90)Y solution, employing a highly quantifiable chemical digestion process. Calibration factors for the manufacturer's ionisation chambers were determined for 1 and 5 ml of the SIR-spheres product placed in Wheaton vials, for both 34% and 44% of (90)Y microsphere concentration.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15963429     DOI: 10.1016/j.apradiso.2005.02.002

Source DB:  PubMed          Journal:  Appl Radiat Isot        ISSN: 0969-8043            Impact factor:   1.513


  2 in total

1.  A review of 3D image-based dosimetry, technical considerations and emerging perspectives in 90Y microsphere therapy.

Authors:  Jim O' Doherty
Journal:  J Diagn Imaging Ther       Date:  2015-04-28

2.  Assessment of the relative contribution of volume and concentration changes in Yttrium-90 labelled resin microspheres on ionization chamber measurements.

Authors:  Nicholas Forwood; Kathy P Willowson; Michael Tapner; Dale L Bailey
Journal:  Australas Phys Eng Sci Med       Date:  2017-11-17       Impact factor: 1.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.